anginera
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00364390)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- anginera
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00364598 | Phase 1 | Dec 1, 2006 | Theregen, Inc., University of Pennsylvania |
| NCT00364390 | Phase 1 | Apr 1, 2006 | Theregen, Inc., University of Maryland, Yale University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Theregen, Inc. | For profit | 2 | 2 | 1 | 2006 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2006 |
4 organizations
Page 1 / 1